Effect of surgical treatment on the cellular immune response of gastric cancer patients

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 3, 2003, Pages 339-345

  Barbieri, C ^a   Fujisawa, M M ^a   Yasuda, C L ^a   Metze, I L ^a   Oliveira, E C ^a   Santos, L M B ^a   Lopes, L R ^a   Andreollo, N A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cellular immune response; Gastric cancer; Immunosuppression; Transforming growth factor beta

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MITOGENIC AGENT; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; BLOOD ANALYSIS; CANCER PATIENT; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GASTRECTOMY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; LYMPHADENECTOMY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFORMATION; MALE; PERIPHERAL LYMPHOCYTE; REVIEW; STOMACH CANCER; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0037361269     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003000300008     Document Type: Review

References (30)

1. Breaux JR, Bringaze W, Chappuis C & Cohn I (1990). Adenocarcinoma of the stomach: A review of 35 years and 1710 cases. World Journal of Surgery, 14: 580-586.
2. Maeta M, Shimizu N, Oka A, Kondo A, Yamashiro H, Tsujitani S, Ikeguchi M & Kaibara N (1994). Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. Journal of Surgical Oncology, 55: 149-153.
3. Lee W-J, Chang K-J, Lee C-S & Chen KM (1994). Selective depression of T-lymphocyte subsets in gastric cancer patients - An implication of immunotherapy. Journal of Surgical Oncology, 55: 165-169.
4. Santos LMB, Yamada FT & Scheinberg MA (1985). Monocyte and lymphocyte interaction in patients with advanced cancer. Evidence for deficient IL-1 production. Cancer, 56: 1553-1558.
5. Sporn MB & Roberts AB (1992). Transforming growth factor beta: recent progress and new challenges. Journal of Cell Biology, 119: 1017-1021.
6. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarezmon M, Derynck R, Sporn MB & Fauci AS (1986). Production of transforming growth-factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. Journal of Experimental Medicine, 163: 1037-1050.
7. Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC & Fauci AS (1986). Effects of transforming growth factor β on the functions of natural killer cells - depressed cytolytic activity and blunting of interferon responsiveness. Journal of Immunology, 136: 3916-3920.
8. Ranges GE, Figari IS, Espevik T & Palladino Jr MA (1987). Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. Journal of Experimental Medicine, 166: 991-998.
9. Gorsch SM, Memoli VA & Stulkel TA (1992). Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in breast cancer. Cancer Research, 52: 6949-6952.
10. Johnson MD, Federspiel CF, Gold LI & Moses HL (1992). Transforming growth factor beta and transforming growth factor beta-receptor expression in human meningioma cells. American Journal of Pathology, 141: 633-642.
11. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI & Korc M (1993). Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856.
12. Holtz J, Meyer HJ & Schmoll HJ (1989). Gastric Carcinoma: Classification, Diagnosis, and Therapy. Springer-Verlag, New York, NY, USA.
13. Santos LMB, Al-Sabbagh A, Londono A & Weiner HL (1994). Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T cells in Peyer's patches of SJL mice. Cellular Immunology, 157: 439-447.
14. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB & Whiteside TL (1991). Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Research, 51: 6153-6162.
15. Ikeda H, Sato N, Matsuura A & Kikuchi K (1993). Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet-ring cell carcinomas. Cancer Research, 53: 3078-3084.
16. Stulle K, Vollmers HP, Marquardt P & Muller-Hermelink HK (1994). Human stomach carcinoma-specific T cells derived from the tumor-draining lymph nodes. British Journal of Cancer, 70: 1053-1059.
17. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB & Lotze MJ (1995). Bone marrow derived dentritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Medicine, 1: 1297-1302.
18. Assoian RK, Fleurdelys BE, Stevenson HC, Miler PJ, Madtes DK, Raines EW, Ross R & Sporn MB (1987). Expression and secretion of type-beta transforming growth factor by activated human macrophages. Proceedings of the National Academy of Sciences, USA, 84: 6020-6024.
19. Lee G, Ellingsworth LR, Gillis S, Wall R & Kincade PW (1987). Beta-transforming growth factors are potential regulators of B lymphopoiesis. Journal of Experimental Medicine, 166: 1290-1299.
20. Gray JD, Hirokawa M, Ohtsuka K & Horwitz DA (1994). Generation of an inhibitory circuit involving CD8+ T cells, IL2 and NK cell-derived TGFβ. Journal of Immunology, 160: 2248-2254.
21. Lee HM & Rich S (1993). Differential activation of CD8+ T cells by transforming growth factor β1. Journal of Immunology, 151: 668-677.
22. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M & Kaibara N (2000). An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Research, 20: 4489-4493.
23. Choi JH, Kim HC, Lim HY, Nam DK, Kim HS, Yi SY, Shim KS & Han WS (1999). Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients. Oncology, 57: 236-241.
24. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S & Sugimachi K (1999). Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. Journal of Clinical Oncology, 17: 607-614.
25. Lee HM & Rich S (1991). Co-stimulation of T cell proliferation by transforming growth factor β1. Journal of Immunology, 147: 1127-1133.
26. Hirayama D, Fujimori T, Satonaka K, Nakamura T, Kitazawa S, Horio M & Nagasako K (1992). Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer. Human Pathology, 23: 681-685.
27. Mizoi T, Ohtani H, Miyazono K, Miyasawa M, Mastsuno S & Nagura H (1993). Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative differences between cancer and stromal cells. Cancer Research, 53: 183-190.
28. Yanagihara K & Tsumuraya M (1992). Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Research, 52: 4042-4045.
29. Naef M, Ishiwata Y, Friess H, Buchler MW, Gold LI & Korc M (1997). Differential localization of transforming growth factor β isoforms in human gastric mucosa and overexpression in gastric carcinoma. International Journal of Cancer, 71: 131-137.
30. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB & Sporn MB (1994). Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proceedings of the National Academy of Sciences, USA, 9: 8772-8776.